2020
DOI: 10.1590/s1678-9946202062083
|View full text |Cite
|
Sign up to set email alerts
|

Abstract: Chloroquine is the first-line therapy against the asexual stages of Plasmodium vivax. There is a high variation of chloroquine plasma levels after therapeutic doses, which can lead to inadequate exposure to the drug. The gender influence was low regarding the disposition of the drug, which is relevant as there are significant physiological variations between male and female patients. The objective of the study was to investigate whether gender modifies the pharmacokinetics parameters of chloroquine in patients… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
references
References 16 publications
0
0
0
Order By: Relevance